Literature DB >> 20980443

Transcription factor E2F-associated phosphoprotein (EAPP), RAM2/CDCA7L/JPO2 (R1), and simian virus 40 promoter factor 1 (Sp1) cooperatively regulate glucocorticoid activation of monoamine oxidase B.

Kevin Chen1, Xiao-Ming Ou, Jason Boyang Wu, Jean C Shih.   

Abstract

Glucocorticoid steroid hormones play important roles in many neurophysiological processes such as responses to stress, behavioral adaption, and mood. One mechanism by which glucocorticoids exert functions in the brain is via the modulation of neurotransmission systems. Glucocorticoids are capable of inducing the activities of monoamine oxidases (MAOs), which degrade monoamine neurotransmitters including serotonin, norepinephrine, phenylethylamine, and dopamine. However, the molecular mechanisms for such induction are not yet fully understood. Here, we report that dexamethasone, a synthetic glucocorticoid hormone, stimulates MAO B (an isoform of MAOs) promoter and catalytic activities via both the fourth glucocorticoid response element (GRE) and simian virus 40 promoter factor 1 (Sp1) binding sites in MAO B promoter. Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation analysis demonstrated that glucocorticoid receptor binds to the fourth GRE in vitro and in vivo. Using Sp1-binding motifs as bait in a yeast one-hybrid system, we identified two novel transcriptional repressors of MAO B, E2F-associated phosphoprotein (EAPP) and R1 (RAM2/CDCA7L/JPO2), that down-regulate MAO B via MAO B core promoter, which contains Sp1 sites. EMSA suggested that EAPP and R1 competed with Sp1 for binding to the Sp1 site in vitro. Moreover, EAPP and R1 reduced Sp1-activated glucocorticoid activation of MAO B promoter. In response to dexamethasone, lower occupancy by EAPP and R1 and higher occupancy by Sp1 were shown at the natural MAO B core promoter. Together, this study uncovers for the first time the molecular mechanisms for glucocorticoid activation of MAO B gene and provides new insights into the hormonal regulation of MAO.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20980443      PMCID: PMC3033708          DOI: 10.1124/mol.110.067439

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  41 in total

1.  Treatment of depression with antiglucocorticoid drugs.

Authors:  O M Wolkowitz; V I Reus
Journal:  Psychosom Med       Date:  1999 Sep-Oct       Impact factor: 4.312

Review 2.  Mechanism of gene expression by the glucocorticoid receptor: role of protein-protein interactions.

Authors:  I J McEwan; A P Wright; J A Gustafsson
Journal:  Bioessays       Date:  1997-02       Impact factor: 4.345

Review 3.  Monoamine oxidase activity and localisation in the brain and the activity in relation to psychiatric disorders.

Authors:  L Oreland; Y Arai; A Stenström; C J Fowler
Journal:  Mod Probl Pharmacopsychiatry       Date:  1983

Review 4.  Corticosteroids and the brain.

Authors:  E R de Kloet; J M Reul; W Sutanto
Journal:  J Steroid Biochem Mol Biol       Date:  1990-11-20       Impact factor: 4.292

Review 5.  Monoamine oxidase: from genes to behavior.

Authors:  J C Shih; K Chen; M J Ridd
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

6.  Retinoic acid activates monoamine oxidase B promoter in human neuronal cells.

Authors:  Jason B Wu; Kevin Chen; Xiao-Ming Ou; Jean C Shih
Journal:  J Biol Chem       Date:  2009-04-28       Impact factor: 5.157

7.  Monoamine oxidase B expression is selectively regulated by dexamethasone in cultured rat astrocytes.

Authors:  P Carlo; E Violani; M Del Rio; M Olasmaa; S Santagati; A Maggi; G B Picotti
Journal:  Brain Res       Date:  1996-03-04       Impact factor: 3.252

Review 8.  Monoamine oxidase inactivation: from pathophysiology to therapeutics.

Authors:  Marco Bortolato; Kevin Chen; Jean C Shih
Journal:  Adv Drug Deliv Rev       Date:  2008-07-04       Impact factor: 15.470

9.  Dual functions of transcription factors, transforming growth factor-beta-inducible early gene (TIEG)2 and Sp3, are mediated by CACCC element and Sp1 sites of human monoamine oxidase (MAO) B gene.

Authors:  Xiao-Ming Ou; Kevin Chen; Jean C Shih
Journal:  J Biol Chem       Date:  2004-03-15       Impact factor: 5.157

Review 10.  Organization of MAO A and MAO B promoters and regulation of gene expression.

Authors:  Kevin Chen
Journal:  Neurotoxicology       Date:  2004-01       Impact factor: 4.294

View more
  25 in total

1.  Near-infrared fluorescence imaging of cancer mediated by tumor hypoxia and HIF1α/OATPs signaling axis.

Authors:  Jason Boyang Wu; Chen Shao; Xiangyan Li; Changhong Shi; Qinlong Li; Peizhen Hu; Yi-Ting Chen; Xiaoliang Dou; Divya Sahu; Wei Li; Hiroshi Harada; Yi Zhang; Ruoxiang Wang; Haiyen E Zhau; Leland W K Chung
Journal:  Biomaterials       Date:  2014-06-21       Impact factor: 12.479

Review 2.  Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2017-12-26       Impact factor: 3.575

3.  Repetitive transcranial magnetic stimulation inhibits Sirt1/MAO-A signaling in the prefrontal cortex in a rat model of depression and cortex-derived astrocytes.

Authors:  Zheng-Wu Peng; Fen Xue; Cui-Hong Zhou; Rui-Guo Zhang; Ying Wang; Ling Liu; Han-Fei Sang; Hua-Ning Wang; Qing-Rong Tan
Journal:  Mol Cell Biochem       Date:  2017-09-25       Impact factor: 3.396

4.  Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.

Authors:  Jason Boyang Wu; Chen Shao; Xiangyan Li; Qinlong Li; Peizhen Hu; Changhong Shi; Yang Li; Yi-Ting Chen; Fei Yin; Chun-Peng Liao; Bangyan L Stiles; Haiyen E Zhau; Jean C Shih; Leland W K Chung
Journal:  J Clin Invest       Date:  2014-05-27       Impact factor: 14.808

5.  Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder: An [11C]SL25.1188 Positron Emission Tomography Study.

Authors:  Sho Moriguchi; Alan A Wilson; Laura Miler; Pablo M Rusjan; Neil Vasdev; Stephen J Kish; Grazyna Rajkowska; Junming Wang; Michael Bagby; Romina Mizrahi; Ben Varughese; Sylvain Houle; Jeffrey H Meyer
Journal:  JAMA Psychiatry       Date:  2019-06-01       Impact factor: 21.596

6.  Coordinated dynamic gene expression changes in the central nucleus of the amygdala during alcohol withdrawal.

Authors:  Kate Freeman; Mary M Staehle; Rajanikanth Vadigepalli; Gregory E Gonye; Babatunde A Ogunnaike; Jan B Hoek; James S Schwaber
Journal:  Alcohol Clin Exp Res       Date:  2012-07-24       Impact factor: 3.455

7.  The reduction of R1, a novel repressor protein for monoamine oxidase A, in major depressive disorder.

Authors:  Shakevia Johnson; Craig A Stockmeier; Jeffrey H Meyer; Mark C Austin; Paul R Albert; Junming Wang; Warren L May; Grazyna Rajkowska; James C Overholser; George Jurjus; Lesa Dieter; Chandra Johnson; Donald B Sittman; Xiao-Ming Ou
Journal:  Neuropsychopharmacology       Date:  2011-06-08       Impact factor: 7.853

8.  Chronic Social Stress and Ethanol Increase Expression of KLF11, a Cell Death Mediator, in Rat Brain.

Authors:  Jeremy Duncan; Niping Wang; Xiao Zhang; Shakevia Johnson; Sharonda Harris; Baoying Zheng; Qinli Zhang; Grazyna Rajkowska; Jose Javier Miguel-Hidalgo; Donald Sittman; Xiao-Ming Ou; Craig A Stockmeier; Jun Ming Wang
Journal:  Neurotox Res       Date:  2015-03-05       Impact factor: 3.911

9.  Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12.

Authors:  Jessica C Amlin-Van Schaick; Sungjin Kim; Christina DiFabio; Min-Hyung Lee; Karl W Broman; Karlyne M Reilly
Journal:  Neuro Oncol       Date:  2012-01-10       Impact factor: 12.300

10.  Valproic acid induces monoamine oxidase A via Akt/forkhead box O1 activation.

Authors:  Jason Boyang Wu; Jean C Shih
Journal:  Mol Pharmacol       Date:  2011-07-20       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.